Authors:
Van Assche, G
Depoortere, I
Thijs, T
Missiaen, L
Penninckx, F
Takanashi, H
Geboes, K
Janssens, J
Peeters, TL
Citation: G. Van Assche et al., Contractile effects and intracellular Ca2+ signalling induced by motilin and erythromycin in the circular smooth muscle of human colon, NEUROG MOT, 13(1), 2001, pp. 27-35
Authors:
Abu El-Asrar, AM
Al-Kharashi, SA
Al-Mansouri, S
Missotten, L
Geboes, K
Citation: Am. Abu El-asrar et al., Langerhans' cells in vernal keratoconjunctivitis express the costimulatorymolecule B7-2 (CD86), but not B7-1 (CD80), EYE, 15, 2001, pp. 648-654
Authors:
Cornillie, F
Shealy, D
D'Haens, G
Geboes, K
Van Assche, G
Ceuppens, J
Wagner, C
Schaible, T
Plevy, SE
Targan, SR
Rutgeerts, P
Citation: F. Cornillie et al., Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease, ALIM PHARM, 15(4), 2001, pp. 463-473
Authors:
Geboes, K
Dekker, W
Mulder, CJJ
Nusteling, K
Citation: K. Geboes et al., Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa, ALIM PHARM, 15(11), 2001, pp. 1819-1826
Authors:
Colpaert, S
Liu, Z
De Greef, B
Rutgeerts, P
Ceuppens, JL
Geboes, K
Citation: S. Colpaert et al., Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model, ALIM PHARM, 15(11), 2001, pp. 1827-1836
Authors:
Liu, ZJ
Geboes, K
Hellings, P
Maerten, P
Heremans, H
Vandenberghe, P
Boon, L
van Kooten, P
Rutgeerts, P
Ceuppens, JL
Citation: Zj. Liu et al., B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis, J IMMUNOL, 167(3), 2001, pp. 1830-1838
Authors:
Colombel, JF
Rutgeerts, P
Malchow, H
Jacyna, M
Nielsen, OH
Rask-Madsen, J
Van Deventer, S
Ferguson, A
Desreumaux, P
Forbes, A
Geboes, K
Melani, L
Cohard, M
Citation: Jf. Colombel et al., Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease, GUT, 49(1), 2001, pp. 42-46
Authors:
D'Haens, G
Lemmens, L
Geboes, K
Vandeputte, L
Van Acker, F
Mortelmans, L
Peeters, M
Vermeire, S
Penninckx, F
Nevens, F
Hiele, M
Rutgeerts, P
Citation: G. D'Haens et al., Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis, GASTROENTY, 120(6), 2001, pp. 1323-1329
Authors:
Liu, ZJ
Geboes, K
Heremans, H
Overbergh, L
Mathieu, C
Rutgeerts, P
Ceuppens, JL
Citation: Zj. Liu et al., Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis, EUR J IMMUN, 31(5), 2001, pp. 1550-1560
Authors:
El-Asrar, AM
Desmet, S
Meersschaert, A
Dralands, L
Missotten, L
Geboes, K
Citation: Am. El-asrar et al., Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus, AM J OPHTH, 132(4), 2001, pp. 551-556
Authors:
D'Haens, G
Swijsen, C
Noman, M
Lemmens, L
Ceuppens, J
Agbahiwe, H
Geboes, K
Rutgeerts, P
Citation: G. D'Haens et al., Etanercept in the treatment of active refractory Crohn's disease: A single-center pilot trial, AM J GASTRO, 96(9), 2001, pp. 2564-2568
Citation: K. Geboes, Crohn's disease, ulcerative colitis or indeterminate colitis - how important is it to differentiate?, ACT GASTR B, 64(2), 2001, pp. 197-200
Authors:
Meuwissen, SGM
Ewe, K
Gassull, MA
Geboes, K
Jewell, D
Pallone, F
Rachmilewitz, D
Rask-Madsen, J
Riddell, BH
Sandborn, BJ
Schmuck, ML
Citation: Sgm. Meuwissen et al., IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine,cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases, EUR J GASTR, 12(1), 2000, pp. 13-18
Authors:
Haustermans, K
Hofland, I
Van de Pavert, I
Geboes, K
Varia, M
Raleigh, J
Begg, AC
Citation: K. Haustermans et al., Diffusion limited hypoxia estimated by vascular image analysis: comparisonwith pimonidazole staining in human tumors, RADIOTH ONC, 55(3), 2000, pp. 325-333